EVA Pharma开始生产抗病毒药物Favipiravir
Eva Pharma是在开罗开展业务的主要国际制药公司之一，
宣布已宣布将开始生产一种基于有效成分“ Favipiravir”的新药，该药物是一种抗病毒化合物，已被证明可有效对抗俄罗斯的新冠状病毒和治疗多个地区的患者。
目前正在俄罗斯以外的其他几个州（包括日本）对这种有效的治疗方法进行测试。
Dr. Riyad Armanius,
Managing Director of Eva Pharma , said
that his company has already started manufacturing the drug within it’s factories, and has already started producing samples,
explaining that there is coordination between Eva and the medical authorities in Egypt to approve that the drug is safe to use in the treatment of patients with the emerging coronavirus during the upcoming period.
Earlier this month, Eva Pharma
announced it had reached a “historic” deal with Gilead Sciences Inc to become the licensed manufacturer of the US company’s antiviral treatment Remdesivir for coronavirus in 127 countries.
Sada El balad
https://see.news/eva-pharma-to-start-manufacturing-antiviral-drug-favipiravir/